Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of CorMedix Inc (NASDAQ: CRMD) closed at $10.11 in the last session, up 2.64% from day before closing price of $9.85. In other words, the price has increased by $2.64 from its previous closing price. On the day, 0.5 million shares were traded.
Ratios:
We take a closer look at CRMD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.96. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on January 13, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On August 26, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $13.
On August 10, 2023, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $6.RBC Capital Mkts initiated its Outperform rating on August 10, 2023, with a $6 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 31 ’24 when Mistry Erin bought 1,500 shares for $9.99 per share. The transaction valued at 14,985 led to the insider holds 52,011 shares of the business.
Hurlburt Elizabeth sold 140,027 shares of CRMD for $1,565,670 on Nov 14 ’24. The EVP now owns 45,397 shares after completing the transaction at $11.18 per share. On Nov 14 ’24, another insider, Hurlburt Elizabeth, who serves as the Officer of the company, bought 140,027 shares for $11.12 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 50.04 while its Price-to-Book (P/B) ratio in mrq is 9.97.
Stock Price History:
Over the past 52 weeks, CRMD has reached a high of $13.85, while it has fallen to a 52-week low of $3.03. The 50-Day Moving Average of the stock is -2.09%, while the 200-Day Moving Average is calculated to be 27.85%.
Shares Statistics:
A total of 60.68M shares are outstanding, with a floating share count of 59.25M. Insiders hold about 2.35% of the company’s shares, while institutions hold 37.76% stake in the company.
